NCT00318786View on ClinicalTrials.gov

Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL

Enrollment

289

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

biphasic insulin aspart

Trial Locations (1)

1000005

Novo Nordisk Investigational Site, Tokyo

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY